Ramipril
Ramipril is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Ramipril; Generic name: RAMIPRIL; Drug class: Angiotensin Converting Enzyme Inhibitor [EPC].
| Brand name | Ramipril |
|---|---|
| Generic name | RAMIPRIL |
| Drug class | Angiotensin Converting Enzyme Inhibitor [EPC] |
| Manufacturer | A-S Medication Solutions |
| Used for | 1 INDICATIONS AND USAGE Ramipril capsules are an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. It may be used alone or in combination with thiazide diuretics ( 1.1 ). In patients 55 years or older at high risk of developing a major cardiovascular event, ramipril capsules are indicated to reduce the risk of myocardial infarction, stroke, or death from cardiovascular causes ( 1.2 ). Ramipril capsules are indicated in stable patients who have demonstrated clinical signs of congestive heart failur |
| Dosage | 2 DOSAGE AND ADMINISTRATION Hypertension: Initial dose is 2.5 mg to 20 mg once daily. Adjust dosage according to blood pressure response after 2 to 4 weeks of treatment. The usual maintenance dose following titration is 2.5 mg to 20 mg daily as a single dose or equally divided doses ( 2.1 ). Reduction in the risk of myocardial infarction, stroke, or death from cardiovascular causes: 2.5 mg once daily for 1 week, 5 mg once daily for 3 weeks, and increased as tolerated to a maintenance dose of 10 |
| Warnings | WARNING: FETAL TOXICITY When pregnancy is detected, discontinue ramipril as soon as possible [see Warnings and Precautions (5.6) ]. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus [see Warnings and Precautions (5.6) ] . WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning When pregnancy is detected, discontinue ramipril as soon as possible (5.6) . Drugs that act directly on the renin-angiotensin system can |
| Active ingredient(s) | RAMIPRIL |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1576188e-efd4-4e14-870e-fd9bd2751c45 |